A Multicenter, Randomized, Double-blind, Placebo-Controlled, 8-Week Study to Evaluate the Safety and Efficacy of Nebivolol and Valsartan Given as a Fixed Dose Combination in Patients With Stage 1 or 2 Essential Hypertension
A Multicenter, Randomized, Double-blind, Placebo-Controlled, 8-Week Study to Evaluate the Safety and Efficacy of Nebivolol and Valsartan Given as a Fixed Dose Combination in Patients With Stage 1 or 2 Essential Hypertension
To evaluate the efficacy and safety of fixed-dose combination of nebivolol and valsartan compared to monotherapy and placebo in patients with stage 1 and stage 2 hypertension.
Inclusion Criteria:
Exclusion Criteria:
Los Angelas, California 90057, United States
Los Angelas, California 90057, United States
Gainsville, Florida 32605, United States
Tamarack, Florida 33321, United States
Glen Falls, New York 12801, United States
Downington, Pennsylvania 19335, United States